Idiopathic inflammatory myopathy
Therapeutic area
Neuromuscular Disease
Rare disease
No
- Definition
- Idiopathic form of inflammatory myopathy.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Idiopathic inflammatory myopathy
- Therapeutic area
- Neuromuscular Disease
- idiopathic inflammatory myopathy
- idiopathic myositis
- Disease mechanisms
- Inflammatory
- Severity
- Severe
- Neuromuscular Disease
- Rheumatology
- MONDO ID
- MONDO:0600023
- Parent condition
- MONDO:0021167
Related records
Broader conditions (10)
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Inflammatory disease
- Muscle tissue disorder
- Musculoskeletal system disorder
- Myopathy
- Myositis disease
- Skeletal muscle disorder
Narrower conditions (27)
- Acquired idiopathic inflammatory myopathy
- Adermatopathic dermatomyositis
- Adult dermatomyositis
- Amyopathic dermatomyositis
- Anti-MDA5 dermatomyositis
- Anti-Mi2 dermatomyositis
- Anti-NXP2 dermatomyositis
- Anti-SAE dermatomyositis
- Anti-TIF1 dermatomyositis
- Antisynthetase syndrome
- Classical dermatomyositis
- Clinically amyopathic dermatomyositis
- Dermatomyositis
- Eosinophilic fasciitis
- Familial idiopathic inflammatory myopathy
- Focal myositis
- Hypomyopathic dermatomyositis
- Idiopathic eosinophilic myositis
- Immune-mediated necrotizing myopathy
- Inflammatory myopathy with abundant macrophages
Trials (20)
- A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
- A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
- A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Add-on Intravenous Immunoglobulins in Early Myositis
- Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
- Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
- Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells
- GC012F in Patients With Autoimmune Diseases
- GC012F Injection in Refractory Idiopathic Inflammatory Myopathy
- IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy
- Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
- MYOPROSP - a Prospective Cohort Study in Myositis
- OM336 in Seropositive Autoimmune Diseases
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Safety Study of CC312 in Autoimmune Disease Patients
Drugs in development (3)
- Nipocalimab Phase 2
- Plamotamab Phase 1
- Rapcabtagene autoleucel Phase 2